We deliver integrated upstream fermentation and downstream harvest equipment solutions tailored for synthetic biology workflows, supporting engineered microbial strains, enzyme production, bio-based chemicals and novel biomolecule development. Our product portfolio spans laboratory, pilot and commercial scales, built to resolve the unique separation challenges of complex fermentation broths while aligning with cGMP, ICH and ISO quality frameworks. As a dedicated equipment supplier, we partner with synthetic biology startups, biomanufacturers and CDMOs to translate genetic engineering breakthroughs into robust, scalable production infrastructure without compromising process integrity.
Our equipment suite comprises modular fermenter platforms, disc stack centrifuges, tangential flow filtration skids, clarification systems and supporting hygienic auxiliary units, engineered for seamless upstream-to-downstream process continuity. Each unit integrates PAT-enabled real-time monitoring, closed-loop automation and hygienic wetted component design, accommodating both batch and continuous fermentation harvest workflows. Our engineering scope covers P&ID layout, CFD flow simulation, process compatibility testing and full skid integration, enabling streamlined technology transfer from lab-scale strain screening to full commercial biomanufacturing campaigns.
Built for stable recovery yields and reduced product degradation, our fermentation and harvest equipment preserves target biomolecules during cell removal, clarification and primary capture stages. Optimized low-shear separation designs minimize host cell protein and nucleic acid contamination, while validated CIP/SIP or single-use options reduce cross-contamination risk and cut downtime between production runs. Precision material selection and traceable component calibration deliver consistent batch performance, simplifying validation packages and regulatory documentation for global product filings.
Partnering with our synthetic biology equipment portfolio unlocks measurable operational and capital value by boosting product recovery rates and lowering overall production expenditure. Our scalable modular architecture shortens manufacturing cycle times and adapts readily to evolving strain and process upgrades, supporting both early-stage clinical batches and large-volume bio-based product commercialization. We provide end-to-end services including equipment customisation, factory acceptance testing, on-site commissioning and lifecycle technical support, empowering synthetic biology manufacturers to accelerate commercialisation while maintaining full regulatory compliance across global markets.
